Ashlee Dunston | Director, Investor Relations and Corporate Communications |
Sanjay Shukla | President & Chief Executive Officer |
Leslie Nangle | Vice President, Research |
Jill Broadfoot | Chief Financial Officer |
Gregory Renza | RBC Capital Markets |
Joe Pantginis | H.C. Wainwright |
Hartaj Singh | Oppenheimer |
Yale Jen | Laidlaw & Co |
Good afternoon, ladies and gentlemen and welcome to aTyr Pharma Second Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. It is now my pleasure to hand the conference call over to Ashlee Dunston, aTyr’s Director of Investor Relations and Corporate Communications.